Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Hoyer

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Transplantation Proceedings|September 2, 1998
Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997)P Keown, B D Kahan, A Johnston, et al.
Pharmacogenetics|May 8, 2001
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humansR Büscher, H Belger, K J Eilmes, et al.
Kidney International|September 28, 2007
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendationsD C Cattran, E Alexopoulos, P Heering, et al.
Pediatric Transplantation|May 10, 2002
Single-dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patientsR Van Damme-Lombaerts, N A Y Webb, P F Hoyer, et al.
Scandinavian Journal of Immunology|June 8, 2012
Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft functionA Hoerning, S Köhler, C Jun, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Transplantation Proceedings|September 2, 1998
Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997)P Keown, B D Kahan, A Johnston, et al.
Pharmacogenetics|May 8, 2001
In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humansR Büscher, H Belger, K J Eilmes, et al.
Kidney International|September 28, 2007
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendationsD C Cattran, E Alexopoulos, P Heering, et al.
Pediatric Transplantation|May 10, 2002
Single-dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patientsR Van Damme-Lombaerts, N A Y Webb, P F Hoyer, et al.
Scandinavian Journal of Immunology|June 8, 2012
Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft functionA Hoerning, S Köhler, C Jun, et al.
Pageof 12